Should You Continue to Hold Integra Stock in Your Portfolio Now?

Key Takeaways IART's CSS segment sees strong global demand, boosted by the Acclarent acquisition and international growth.IART's Tissue Technologies gains momentum with Integra Skin, DuraSorb and planned Braintree production.Integra faces macro risks, supply disruptions, tariffs and a stretched liquidity position.Integra LifeSciences Holdings Corporation (IART) is seeing healthy demand for its industry-leading products within the Codman Specialty Surgical (“CSS”) segment. The company is also successfully ex ...